ロード中...

Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus

Hepatocellular carcinoma (HCC) patients with main portal vein tumor thrombus have a median survival time of only about 4 months. We therefore compared the safety and efficacy of endovascular brachytherapy (EVBT) and sequential three-dimensional conformal radiotherapy (3-DCRT). From a cohort of 176 p...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Yu, Tian-Zhu, Zhang, Wen, Liu, Qing-Xin, Li, Wen-Hui, Ma, Jing-Qin, Zhang, Zi-Han, Yang, Min-Jie, Wang, Jian-Hua, Chen, Bing, Zeng, Shao-Chong, Luo, Jian-Jun, Liu, Ling-Xiao, Yan, Zhi-Ping
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355329/
https://ncbi.nlm.nih.gov/pubmed/28076848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14520
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!